Physician profile
Farooque Khan
NPI 1063457208
$372.90
in general payments reported to CMS, 2019-2025
9 companies · $81.33 in 2025
The $81.33 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.11 · 2020: $30.28 · 2021: $28.61 · 2022: $16.52 · 2023: $60.89 · 2024: $115 · 2025: $81.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $93.22 | 2024 | Senza |
| Medtronic, INC. | $81.33 | 2025 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $77.86 | 2021-2024 | Belbuca |
| Janssen Pharmaceuticals, INC | $43.71 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.15 | 2023 | Relistor |
| Biohaven Pharmaceutical Holding Company Ltd. | $16.52 | 2022 | |
| Boston Scientific Corporation | $15.88 | 2019 | |
| Daiichi Sankyo INC. | $12.23 | 2019 | |
| Spr Therapeutics, INC | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farooque Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.